Abstract
dc:description.abstractWhen compared to static cold storage (SCS), the hypothermic machine perfusion (HMP) of pretransplant kidneys confers a therapeutic effect to transplant recipients. The mechanisms conferring this benefit are not fully understood, however are thought to include a metabolic component. The first experiments in this thesis demonstrated that metabolic differences exist between HMP and SCS stored kidneys. If properly optimised, HMP potentiates further gains for transplant recipients. However, the low throughput of organ storage research reduces the rate new HMP protocols are assessed. Therefore, a novel in vitro model of organ preservation was created. This model permits high-throughput control of fluid shear stress and oxygenation, and both of these environmental stimuli were found to be independent mediators of cellular survival after simulated preservation. Additionally, oxygen supplementation modulated de novo metabolism in hypothermicly stored proximal tubule cells. When trialled in whole organ models of HMP, high-dose perfusate oxygenation led to increased cortical concentrations of adenosine triphosphate, and also increased the concentrations of citric acid cycle metabolites produced de novo. The final chapters of this thesis chart an international collaborative effort to probe the minimal oxygen delivery strategy capable of inducing ex vivo benefit, followed by in vivo validation using animal auto-transplantation models.
Degree
thesis:*- Name dc:type.qualificationname
- d_ph
- Level dc:type.qualificationlevel
- d_ph
- Grantor dc:publisher.institution
- University of Birmingham
- Year dc:date.issued
- 2020
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Smith, Thomas Brendan
- ORCID person:identifier.orcid
Subjects
dc:subject × 4Rights
- Language dc:language.dcterms_iso639_2
- eng